Diabetic Eye Disease News and Research

RSS
Diabetic eye disease refers to a group of eye problems that people with diabetes may face as a complication of diabetes. All can cause severe vision loss or even blindness. Diabetic eye disease may include, diabetic retinopathy — damage to the blood vessels in the retina, Cataract—clouding of the eye's lens, glaucoma—increase in fluid pressure inside the eye that leads to optic nerve damage and loss of vision. A person with diabetes is nearly twice as likely to get glaucoma as other adults.
Older people with diabetes are susceptible to nonfatal cardiovascular complications, hypoglycemic events

Older people with diabetes are susceptible to nonfatal cardiovascular complications, hypoglycemic events

Optic flow enables perception despite blur image

Optic flow enables perception despite blur image

Researchers work on stem cell treatments to halt vision loss caused by diabetic retinopathy

Researchers work on stem cell treatments to halt vision loss caused by diabetic retinopathy

Weill Cornell to purchase innovative equipment to help detect and treat diabetic retinopathy

Weill Cornell to purchase innovative equipment to help detect and treat diabetic retinopathy

Joslin Diabetes Center, Mass. Eye and Ear partner to form clinical and research alliance

Joslin Diabetes Center, Mass. Eye and Ear partner to form clinical and research alliance

Genentech receives FDA approval for Lucentis to treat diabetic macular edema

Genentech receives FDA approval for Lucentis to treat diabetic macular edema

Lucentis receives FDA approval for treatment of diabetic macular edema

Lucentis receives FDA approval for treatment of diabetic macular edema

Researchers hope to use experiences of people with long-term T1D to benefit others

Researchers hope to use experiences of people with long-term T1D to benefit others

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

First comprehensive framework to close the gap on Indigenous eye health for Australians

First comprehensive framework to close the gap on Indigenous eye health for Australians

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

JDRF initiates enrollment in metformin clinical study for type 1 diabetes

JDRF initiates enrollment in metformin clinical study for type 1 diabetes

Akebia commences dosing in AKB-9778 Phase 1 study for diabetic macular edema and retinopathy

Akebia commences dosing in AKB-9778 Phase 1 study for diabetic macular edema and retinopathy

Omron's home monitors can help control high blood pressure

Omron's home monitors can help control high blood pressure

JDRF, iCo Therapeutics collaborate for iCo-007 Phase 2 trial in DME

JDRF, iCo Therapeutics collaborate for iCo-007 Phase 2 trial in DME

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

Genentech's Lucentis Phase III trials in DME meets primary endpoints

Genentech's Lucentis Phase III trials in DME meets primary endpoints

Genentech announces positive outcomes from Lucentis Phase III trial against DME

Genentech announces positive outcomes from Lucentis Phase III trial against DME

Phase III RISE study of Lucentis for DME meets primary endpoint

Phase III RISE study of Lucentis for DME meets primary endpoint

Diabetes Management – a new journal addressing the management issues of a complex disease

Diabetes Management – a new journal addressing the management issues of a complex disease